Comparative genomic hybridization (CGH) |
| Comparative Genomic Hybridization (CGH) has also been termed Copy Ratio Reverse Cytogenetics (CRRC)... |
|
DNA sequence-based HLA typing method |
| The present invention relates to a method for determining the nucleic acid sequence of one or more ... |
|
Alterations in the long QT syndrome genes KVLQT1 and SCN5A and methods for detecting same |
| OF THE INVENTION The present invention relates to alterations in the KVLQT1, HERG, SCN5A, KCNE1 ... |
|
Method for forming image |
| OF THE INVENTION In accordance with the present invention there is provided a method for ... |
|
WF11243 substance |
| We claim: 1. An isolated compound having formula (I): ##STR4## or a salt thereof. 2. A method for ... |
|
Electrophoretic method for the isolation and separation of microorganisms and cell populations |
| It is an object of the invention to provide a novel electrophoretic method for the separation of ... |
|
Human antithrombin III |
| The present invention is directed to the means and methods of producting human antithrombin III via ... |
|
Cryptophycins |
| OF THE INVENTION The present invention provides novel cryptophycin compounds having the following ... |
|
Method for recovery of refined .alpha.-galactosidase |
| OF THE INVENTION The methods heretofore suggested for the refinement of .alpha.-galactosidase ... |
|
|
Bacillus thuringiensis toxins active against hymenopteran pests
| Details |
Inventors: Payne, Jewel M.; Kennedy, M. Keith; Randall, John Brookes; Meier, Henry; Uick, Heidi Jane; Foncerrada, Luis; Schnepf, H. Ernest; Schwab, George E.; Fu, Jenny;
Assignee: Mycogen Corporation (San Diego, CA)
Primary Examiner: Railey, II; Johnny F.
Assistant Examiner:
Attorney, Agent or Firm: Saliwanchik, Lloyd & Saliwanchik
Novel Bacillus thuringiensis toxins with hymenopteran activity are described. |
|
DETAILED DESCRIPTION The subject invention concerns novel Bacillus thuringiensis (B. t. ) isolates and genes therefrom which encode novel hymenopteran-active proteins. The novel B. t. isolates, known herein as Bacillus thuringiensis PS140E2 (B. t. PS140E2), Bacillus thuringiensis PS86Q3 (B. t. PS86Q3) and Bacillus thuringiensis PS211B2 (B. t. PS211B2), as well as toxins from these isolates, can be used to control pests such as fire ants, carpenter ants, argentine ants, and pharaoh ants. The subject invention also includes mutants of the above isolates which have substantially the same pesticidal properties as the parent isolate. Procedures for making mutants are well known in the microbiological art. Ultraviolet light and nitrosoguanidine are used extensively toward this end. The subject invention also concerns novel toxins active against ants. A further aspect of the invention concerns genes encoding these formicidal toxins. The subject invention provides the person skilled in this art with a vast array of formicidal toxins, methods for using these toxins, and genes that encode the toxins. The genes or gene fragments of the invention encode Bacillus thuringiensis . delta. -endotoxins which have hymenopteran activity. The genes or gene fragments can be transferred to suitable hosts via a recombinant DNA vector. One aspect of the invention is the discovery of a generalized chemical formula common to a wide range of formicidal toxins. This formula can be used by those skilled in this art to obtain and identify a wide variety of toxins having the desired formicidal activity. The subject invention provides other teachings which enable the skilled practitioner to identify and isolate ant-active toxins and the genes which code therefor. For example, characteristic features of ant-active toxin crystals are disclosed herein. Furthermore, characteristic levels of amino acid homology can be used to characterize the toxins of the subject invention. Yet another characterizing feature pertains to immunoreactivity of the toxins with certain antibodies
|
| Related patents |
|
|
Fluorescein labelled phosphoramidites
In one aspect, the invention provides a compound of the following formula: ##STR1## wherein the substituent ##STR2## is linked to the fluorescein carbon 1, 2, 3, or 4 ...
|
|
|
Labelled oligonucleotides synthesized on solid-supports
OF THE PREFERRED EMBODIMENTS Reference will now be made in detail to the preferred embodiments of the invention, examples of which are illustrated in the accompanying ...
|
|
|
Alkylene oxide modified hardwood cellulose
What is claimed is: 1. A process for the preparation of cellulose acetate comprising: mercerizing cellulosic material derived from hardwood in a caustic mercerizing ...
|
|
|
Method for polymer synthesis using arrays
What is claimed is: 1. A method of synthesis of a polymer chain in a synthesis apparatus by sequentially adding polymer units thereto, said synthesis apparatus including ...
|
|
|
Pyrrolo[2,3-d]pyrimidine derivatives, process for producing the same and pharmaceutical preparation comprising the same as active ingredient
We claim: 1. A pyrrolo[2,3-d]pyrimidine derivative represented by the general formula I: ##STR218## wherein R.sup.1 represents a hydrogen atom, or an unsubstituted or ...
|
|
|
Promoter for neuropeptide FF and use thereof for therapy and diagnostics
OF THE INVENTION We report here the cloning of the 5'-flanking region of the NPFF gene from mouse, rat and human. Totally 9.8 kb, 1.5 kb and 1.3 kb of the NPFF promoter ...
|
|
|
Transcriptional activators, and compositions and uses related thereto
OF THE INVENTION I. General Protein-encoding genes in eukaryotes are transcribed by RNA polymerase II (pol II), a multisubunit enzyme that is brought to an appropriate ...
|
|
|
Diagnostic probes for pneumocystis carini
OF THE INVENTION This invention relates to a method for diagnosing for Pneumocystis carinii by detecting the presence of a nucleic acid sequence containing the 26S rRNA ...
|
|
|
Peanut allergens and methods
OF THE INVENTION In accordance with a preferred embodiment of the present invention, a monoclonal antibody (MAb) based enzyme-linked immunosorbent assay (ELISA) and ...
|
|
|
Method for sequencing DNA using biotin-strepavidin conjugates to facilitate the purification of primer extension products
OF THE INVENTION Applicants' invention provides a simplified method for isolating primer extension products from template-directed DNA polymerase reactions. For the ...
|
|
|